INTRODUCTION {#sec1-1}
============

After undergoing cardiac surgery, most patients have a short Intensive Care Unit (ICU) and hospital stay. However, up to 10% of patients have a complicated postoperative course because of organ dysfunction or multiple organ failure resulting in increased burden on the hospital resources and costs.\[[@ref1]\] Limited cardiovascular reserve and an inadequate hemodynamic response to postoperative surgical stress have been shown to be independent predictors of a prolonged ICU stay.\[[@ref2][@ref3]\]

Cardiac surgery, at present, is being conducted in an increasingly high-risk population as it is backed by continually improving surgical strategy and technology.\[[@ref4]\] Shoemaker *et al*. showed that high-risk cardiac surgical patients had increased morbidity and mortality and the survivors had consistently higher postoperative cardiac output and oxygen delivery than those who died.\[[@ref5]\] An understanding emerged that the high mortality rate might be reduced, if the flow-related cardiovascular values become additional goals for perioperative management. An indicator of low cardiac output, global tissue hypoxia is a key development proceeding to multiorgan failure and death.\[[@ref6]\] It is in the immediate postcardiopulmonary bypass (CPB) period when the recognition and treatment produce maximal benefit in outcome.\[[@ref7]\]

Goal-directed therapy (GDT) is a term used to describe the use of cardiac output or similar parameters to guide intravenous (IV) fluid and inotropic therapy.\[[@ref8]\] In the present study, GDT was used to optimize the various hemodynamic variables in the post-CPB period in high-risk patients with European system for cardiac operative risk evaluation (EuROSCORE)\[[@ref9]\] ≥3 undergoing coronary artery bypass grafting (CABG) in the study group, whereas the control group comprised patients managed without using GDT. In the patients receiving GDT, the additional aims were to maintain the cardiac index (CI) between 2.5 and 4.2 L/min/m^2^, stroke volume index (SVI) 30--65 ml/beat/m^2^, systemic vascular resistance index (SVRI) 1500--2500 dynes/s/cm^5^/m^2^, oxygen delivery index (DO~2~I) 450--600 ml/min/m^2^, continuous central venous oxygen saturation (ScVO~2~) \>70%, and stroke volume variation (SVV) \<10%. All data gathered in this study were derived using the FloTrac™ (a new minimally invasive cardiac output monitor) cardiac output sensor, and the PreSep™ catheter in conjunction with the Vigileo monitor (Edwards Life Sciences, Irvine, CA, USA).

Besides hemodynamic parameters, a plethora of biomarkers pertaining to myocardial, renal function, and the overall tissue perfusion have been described in recent years. The biomarkers such as brain natriuretic peptide (BNP) and neutrophil gelatinase-associated lipocalin (NGAL) correlate well with the clinical outcomes in various studies involving the use of GDT.\[[@ref10][@ref11]\] This study also aimed at comparing the biomarkers between the patients undergoing CABG with or without GDT for establishing the utility of GDT in the perioperative care of high-risk cardiac surgical patients.

MATERIALS AND METHODS {#sec1-2}
=====================

The study was conducted in two cardiac surgical centers after obtaining ethical clearance from the Institutional Review Board and informed consent. One hundred and thirty patients of either sex with a EuroSCORE ≥3 undergoing CABG were included in this prospective randomized controlled study. The patients were divided randomly into two groups, namely, control and GDT groups, by the sealed envelope technique. Patients with cardiac dysrhythmias and contraindication to the central venous cannulation were excluded from the study. Patients requiring the initiation of intra-aortic balloon pump (IABP) therapy were excluded from the study because the FloTrac™ is not equipped to identify the waveforms of arterial pressure waveform while using IABP.

Induction and maintenance of general anesthesia was done in accordance with the institutional protocol. Electrocardiogram (ECG), oxygen saturation (SpO~2~), invasive blood pressure, central venous pressure (CVP) and arterial blood gas (ABG), urine output, and EtCO~2~ monitoring were common to both the groups. In addition, the CI using FloTrac/volumeView set (Edwards Life Sciences Ltd.) and the ScVO~2~ using PreSep catheter were monitored in the GDT group. A VolumeView™ cardiac output monitoring sensor was connected to the radial arterial cannula in the GDT group. PreSep™ catheter (continuous central venous oximetry) was inserted in the GDT group. The baseline readings (T~1~) of heart rate (HR), mean arterial pressure (MAP), CVP, SpO~2~, and ABG were recorded. The additional baseline readings (T~1~) of CI, SVRI, DO~2~I, SVI, SVV, and ScVO~2~ were recorded in the patients in the GDT group. The blood samples were collected for T~1~ values of BNP, NGAL, and lactate in all the patients.

The CPB was initiated after systemic heparinization and was maintained as per standard institutional protocols. The rewarming was accompanied by administering IV infusion of dobutamine at 5 µg/kg/min and 0.5 µg/kg/min nitroglycerin or any other vasoactive/vasodilator drug depending on patients' condition. After separation from CPB, protamine sulfate was administered in a dose of 1.2 mg/mg of heparin to antagonize the effects of heparin. Thereafter, the patients received 0.1 U/kg of platelet transfusion. All patients received fluids to maintain the CVP between 6 and 8 mmHg\[[@ref12]\] and MAP was maintained between 90 and 105 mmHg using inotropic agents (dobutamine, dopamine, adrenaline, noradrenaline, and milrinone) and vasodilators. ABG and urinary output was monitored on an hourly basis, and the biochemical abnormalities corrected as necessary. Hematocrit (HCT) values were maintained at or above 30% with packed cell transfusions.

The goal-directed therapy algorithm {#sec2-1}
-----------------------------------

In accordance with the GDT, if the CI was \<2.5 L/min/m^2^, CVP \<6 mmHg, or SVV \>10%, fluids (100 ml aliquots of fluid) were given intravenously till the target CVP and SVV levels were achieved \[[Figure 1](#F1){ref-type="fig"}\]. Inotropic agents and vasodilators were adjusted to maintain the parameters within the target values. The choice of inotropes was determined by MAP, SV, and SVRI. If ScVO~2~ was \<70%, packed red cells were administered to maintain HCT \>30% and if ScVO~2~ continued to be \<70%, GDT was initiated to achieve the CI at 2.5--4.2 L/min/m^2^, SVI at 30--65 ml/beat/m^2^, SVRI at 1600--2600 dyne/s/cm^5^/m^2^, DO~2~I at 450--600 ml/min/m^2^, ScVO~2~ \>70%, and SVV \<10%; in addition to the goals in the standard care such as CVP 6--8 mmHg, MAP at 90--105 mmHg, ABG analysis values (pH 7.35--45, PaO~2~ \>100 mmHg, and PaCO~2~ 35--45 mmHg), SpO~2~ \>95%, HCT \>30%, and urine output \>1 ml/kg/h. The monitoring was gradually withdrawn after 24 h.

![The step-wise algorithm followed in the study to allocate, study, and manage the patients receiving goal-directed and conventional therapy](ACA-19-638-g001){#F1}

The parameters recorded at the closure of sternum were designated as T~2~ and blood lactate (T~2~) was estimated. All patients were mechanically ventilated in the ICU and monitored with FlowTrac for 24 h. HR, MAP, SpO~2~, CVP, and peripheral temperature were monitored continuously and recorded at 0 (T~3~), 6 (T~4~), 12 (T~5~), and 24 (T~6~) h after transfer to the ICU. Blood samples were collected postoperatively at 6 and 24 h for T~4~ and T~6~ values of BNP and NGAL and 0, 6, 12, and 24 h for T~3~, T~4~, T~5~, and T~6~ values of lactate.

Early postoperative care in the ICU was jointly determined by the cardiac surgical and ICU staff, as per standard practice. Patients were weaned off when they were fully awake and adequately rewarmed (core temperature ≥36°) with normal skeletal muscle power, hemodynamically stable with normal chest radiograph and ABG, chest-tube drainage \<100 ml/h, and urine output \>1 ml/kg/h. All extubated patients were transferred from the ICU on the 2^nd^ day unless inotropes or vasodilator drugs were necessary. A 12-lead ECG was performed on the day 3. The criteria for discharge from hospital comprised a stable cardiac rhythm, oral temperature \<99°F, HCT ≥25%, oral intake of a minimum of 1000 calories/day, and successful completion of exercise testing that included independent ambulation, no significant wound-related complications, and an adequate home support system. Patients were contacted by phone at 30 days and their medical records reviewed to ascertain if they experienced any adverse outcomes.

Statistical analysis {#sec2-2}
--------------------

Discrete categorical data were presented as number or percentage. The normality of quantitative data was checked by measures of Kolmogorov--Smirnov tests of normality. Continuous data were written either in the form of its mean and standard deviation or in the form of its median and interquartile range, as per the requirement. For normally distributed data, *t*-test was applied for statistical analysis of two groups. For skewed data, nonparametric Mann--Whitney U-test was used for statistical analysis of two groups. For time-related variable, Wilcoxon signed-rank test was applied. For categorical data, comparisons were made by Pearson\'s Chi-square test or Fisher\'s exact test as appropriate. All the statistical tests were two-sided and were performed at a significance level of α = 0.05. Analysis was conducted using IBM SPSS Statistics (version 22.0, IBM corporation, USA).

RESULTS {#sec1-3}
=======

To begin with, there were a total of 130 patients. Five patients from both the groups were excluded from the study since three patients in the control and one in the GDT group required IABP and postoperative atrial or ventricular fibrillation resulted in two and four patients in the control and the study group, respectively. The results of the remaining sixty patients in each group were analyzed. Demographic data and EuroSCORE, duration of CPB, duration of aortic cross-clamping (AOXCL), and an average number of grafts/patient were comparable \[[Table 1](#T1){ref-type="table"}\]. HR, MAP, CVP, SpO~2~, and ABG at various time intervals were comparable between the groups \[[Table 2](#T2){ref-type="table"}\]. The patients in the GDT group produced more urine during the study period, which was not statistically significant from the result of the control. ScVO~2~, CI, SVV, SVRI, SVI, and DO~2~I were maintained within the physiological values in the GDT group.

###### 

Demographic characteristics of the two groups

  Parameter          Control group (*n*=60)   GDT group (*n*=60)   *P*
  ------------------ ------------------------ -------------------- -------
  Age (years)        61.30±5.60\*             61.17±5.09\*         0.892
  Male:female        42:18                    40:20                0.695
  Height (cm)        160.70±5.18\*            159.98±3.30\*        0.448
  Weight (kg)        72.90±8.79\*             72.97±9.39\*         0.968
  EuroSCORE          4.15±0.84\*              4.13±0.81\*          0.955
  CPB (min)          99.22±6.66\*             99.08±7.63\*         0.919
  AOXCL (min)        57.57±4.00\*             57.50±5.20\*         0.937
  Number of grafts   3.43±0.64\*              3.53±0.79\*          0.695

\*Standard deviation, *P*\<0.05 is considered significant. GDT: Goal-directed therapy, CPB: Cardiopulmonary bypass, AOXCL: Aortic cross clamping, EuroSCORE: European system for cardiac operative risk evaluation

###### 

Heart rate, mean arterial pressure, and central venous pressure in the two groups

  Parameter    Time            Control group (*n*=60)   GDT group (*n*=60)   *P*
  ------------ --------------- ------------------------ -------------------- -------
  Heart rate   T~1~            69.42±5.02\*             68.17±6.85\*         0.257
  T~2~         92.18±7.24\*    93.75±6.51               0.215                
  T~3~         99.75±8.29\*    100.45±7.69\*            0.633                
  T~4~         99.95±8.30\*    102.37±6.13\*            0.072                
  T~5~         101.95±8.60\*   103.33±6.10\*            0.312                
  T~6~         100.00±6.81\*   100.92±7.11\*            0.473                
  MAP          T~1~            89.33±6.98\*             91.57±7.17\*         0.087
  T~2~         94.20±6.54\*    94.78±6.85\*             0.634                
  T~3~         96.07±6.06\*    97.82±4.16\*             0.068                
  T~4~         94.73±6.37\*    96.78±5.65\*             0.065                
  T~5~         94.98±5.39\*    97.02±5.91\*             0.052                
  T~6~         98.30±6.38\*    100.45±5.59\*            0.052                
  CVP          T~1~            6.50±0.93\*              6.08±1.09\*          0.117
  T~2~         6.42±0.56\*     6.45±0.77\*              0.753                
  T~3~         6.22±0.49\*     6.35±0.58\*              0.175                
  T~4~         6.17±0.46\*     6.3±0.80\*               0.182                
  T~5~         6.37±0.48\*     6.4±0.58\*               0.736                
  T~6~         6.28±0.52\*     6.53±0.87\*              0.059                

\*Standard deviation, *P*\<0.05 is considered significant. T~1~ (baseline), T~2~ (sternal closure), T~3~ (0), T~4~ (6), T~5~ (12), T~6~ (24) h in ICU. ICU: Intensive Care Unit, MAP: Mean arterial pressure, CVP: Central venous pressure, GDT: Goal-directed therapy

There was statistically significant difference in the extra volume used (343.33 ± 62.02 and 376.33 ± 55.23, *P* = 0.003) and the number of times the inotropic agent was changed (2.77 ± 0.91 and 3.12 ± 0.80, *P* = 0.029) in the control and GDT groups, respectively \[[Table 3](#T3){ref-type="table"}\]. The average duration of ventilation (19.89 ± 3.96 vs. 18.05 ± 4.53 h, *P* = 0.025), hospital stay (7.94 ± 1.64 vs. 7.17 ± 1.93d, *P* = 0.025), and ICU stay (3.74 ± 0.59 vs. 3.41 ± 0.75 d, *P* = 0.012) was significantly less in the GDT group, compared to those in the control group \[[Table 3](#T3){ref-type="table"}\]. The duration of inotropic support was less in the GDT group though not significant as compared to the control. One patient in GDT group and three patients in the control group had renal dysfunction, which improved by administering diuretics. Total four patients (one in GDT and three in control) required IABP support. There were two mortalities in the study group and six mortalities in the control group during the study period. The causes ranged from malignant arrhythmias to refractory hemodynamic instability.

###### 

Comparison of the outcomes between the control and the goal-directed therapy group

  Parameter                            Control group    GDT group        *P*
  ------------------------------------ ---------------- ---------------- -------
  Average extra volume added           343.33±62.02\*   376.33±55.23\*   0.003
  Number of times inotropes adjusted   2.77±0.91\*      3.12±0.80\*      0.029
  Duration of ventilation (h)          19.89±3.96\*     18.05±4.53\*     0.025
  Duration of inotrope usage (days)    3.09±0.59\*      2.81±0.94\*      0.063
  Length of ICU stay (days)            3.74±0.59\*      3.41±0.75\*      0.012
  Length of hospital stay (days)       7.94±1.64\*      7.17±1.93\*      0.025
  Mortality                            6/60             2/60             0.272

\*Standard deviation, *P*\<0.05 is considered significant. Apart from the first two parameters, the *n* for the outcome measures for the control group was 54 and 58 for the GDT group in view of the mortality. GDT: Goal-directed therapy, ICU: Intensive Care Unit

With regard to the biomarkers, the continuation of GDT in the ICU helped reduction in the lactate levels at T~4~ onward, whereas the control group recorded maximum lactate levels at T~5~ \[[Table 4](#T4){ref-type="table"}\]. At the same time, BNP and NGAL were significantly higher in the control group at T~6~ compared to the GDT group \[[Table 4](#T4){ref-type="table"}\].

###### 

Comparison of biomarkers between the two groups

  Biomarker          Time             Control group (*n*=60)   GDT group (*n*=60)   *P*
  ------------------ ---------------- ------------------------ -------------------- -------
  BNP (pg/mL)        T~1~             152.27±11.60\*           153.72±9.41\*        0.454
  T~4~               187.85±13.34\*   184.20±10.24\*           0.095                
  T~6~               207.70±28.44\*   198.98±9.33\*            0.026                
  NGAL (ng/mL)       T~1~             77.45±12.86\*            81.25±11.29\*        0.088
  T~4~               116.95±16.76\*   112.62±9.79\*            0.086                
  T~6~               127.45±13.52\*   122.18±8.85\*            0.013                
  Lactate (mmol/L)   T~1~             1.00±0.30\*              1.01±0.29\*          0.752
  T~2~               2.00±0.60\*      2.03±0.59\*              0.752                
  T~3~               2.52±0.40\*      2.38±0.47\*              0.015                
  T~4~               4.72±0.43\*      4.51±0.53\*              0.024                
  T~5~               5.22±0.64\*      4.14±0.55\*              \<0.001              
  T~6~               3.77±0.31\*      3.23±0.41\*              \<0.001              

\*Standard deviation, *P*\<0.05 is considered significant). T~1~ (baseline), T~2~ (sternal closure), T~3~ (0), T~4~ (6), T~5~ (12), T~6~ (24) h in ICU. ICU: Intensive Care Unit, GDT: Goal-directed therapy, BNP: Brain natriuretic peptide, NGAL: Neutrophil gelatinase-associated lipocalin

DISCUSSION {#sec1-4}
==========

Organ dysfunction and multiple organ failure remain the main causes of prolonged hospital stay after cardiac surgery.\[[@ref1]\] Cardiac surgery patients are at risk of inadequate oxygen delivery in view of extracorporeal circulation and limited cardiovascular reserve.\[[@ref3][@ref13]\]

The aim of GDT is to maintain the CI, CVP, MAP, SVRI, DO~2~I, SVI, SVV, ScVO~2~, ABG, and urine output within the physiological limits by active intervention. Pölönen *et al*. studied 403 cardiac surgery patients and concluded that maintaining mixed venous oxygen saturation (SvO2) \>70%, decreases the length of stay (LOS)-ICU and LOS-hospital.\[[@ref13]\] Patients in the high-risk group who tend to have increased morbidity and mortality may benefit from intensive monitoring and early interventions. Therefore, in this study, we wished to study the utility of GDT in patients who with EuroSCORE ≥3 points (medium and high-risk).

Mixed venous oxygen saturation is ideally measured by estimating the oxygen content of the blood drawn from the pulmonary artery through pulmonary artery catheter (PAC). Goldman *et al*. studied the importance of ScVO~2~ in 31 patients with myocardial infarction.\[[@ref14]\] PreSep™ central venous oximetry catheter can be used to continuously monitor the ScVO~2~ (though not similar to SvO~2~, correlates well with SvO~2~). The mixed venous oxygen saturation estimated from the superior vena cava was found to be 5%--13% lower than that estimated from the PAC.\[[@ref15]\]

In cardiac surgery, GDT was commenced using a noninvasive method such as esophageal Doppler instead of the PAC to measure the cardiac output.\[[@ref16][@ref17][@ref18]\] Unlike the FloTrac™, Doppler probe is not readily tolerated by conscious patients, restricting its use to patients who are ventilated, and the PAC is invasive with its own set of complications.\[[@ref8]\] Studies by Manecke *et al*., McGee *et al*., and Chakravarthy *et al*., have validated the Vigileo system.\[[@ref19][@ref20][@ref21]\] However, Opdam *et al*. showed a limited correlation for CI between FloTrac™ and PAC.\[[@ref22]\] A study by Smetkin *et al*. showed that a goal-directed algorithm based on continuous measurement of ScVO~2~ could improve the course of the postoperative period after CABG on the beating heart.\[[@ref23]\] In a 15-year follow-up, Rhodes *et al*. evaluated GDT in high-risk surgical patients, demonstrating improved long-term outcomes.\[[@ref24]\]

The authors had previously conducted a clinical outcome comparison study between the GDT and the control groups in a small number of patients with inconclusive results.\[[@ref25]\] Keeping in view the advent and validation of biomarkers for predicting organ dysfunction after cardiac surgery,\[[@ref10][@ref11]\] the authors planned a comparison between the GDT and conventional hemodynamic management with clinical and biochemical outcomes in a larger number of patients.

The average duration of ventilation, hospital stay, ICU stay was significantly less in the GDT group, compared to those in the control group \[[Table 3](#T3){ref-type="table"}\]. The duration of inotropic support was less in the GDT group though not significant as compared to the control. There was statistically significant difference in the extra volume used and the number of times the inotropic agent was changed in the control and GDT groups, both being higher in the GDT group to meet the desired hemodynamic goals.

As depicted in [Figure 2](#F2){ref-type="fig"}, the continuation of GDT in the perioperative period in the ICU helped in stabilization of the lactate levels at T~4~ onward, whereas the control group recorded maximum lactate levels at T~5.~ It was noteworthy that NGAL levels (as well as BNP) were significantly higher in the control group after 24 h as compared to the GDT group though the urine output difference between the groups was still insignificant \[[Figure 3](#F3){ref-type="fig"}\]. This highlights the importance of biomarkers in early detection of organ dysfunction after cardiac surgery. Close hemodynamic, clinical, and biomarker-based monitoring continued from the perioperative to the intensive care setting provides early mobilization in a safe manner postcardiac surgery.\[[@ref26][@ref27][@ref28]\]

![The lactate at T~1~ (baseline), T~2~ (sternal closure), T~3~ (0), T~4~ (6), T~5~ (12), and T~6~ (24) h in Intensive Care Unit. The arrow shows the peak in the groups](ACA-19-638-g002){#F2}

![The brain natriuretic peptide, neutrophil gelatinase-associated lipocalin, average hourly urine output at T~1~, T~4~, T~6~, where the rise in brain natriuretic peptide/neutrophil gelatinase-associated lipocalin is clear at T~6~](ACA-19-638-g003){#F3}

Limitations {#sec2-3}
-----------

This study had a few limitations: In spite of involving a considerable number of patients in a randomized fashion, the study could not be blinded. Second, the present study being a multicenter study, the patients enrolled in the study were operated upon by center-specific surgical teams. Preload markers of global end-diastolic volume index and extravascular lung water could not be completed in all sixty patients; hence their values were not included in the study. These markers which give more information on volume status should be part of a futuristic trial, as it substantiates adequately the efficacy of GDT.

CONCLUSION {#sec1-5}
==========

Perioperative GDT can shorten the duration of ventilator dependency, ICU and hospital stay in high-risk cardiac surgical patients. The significantly lower levels of biomarkers in GDT group further support the importance of optimizing the hemodynamic parameters for the maintenance of tissue perfusion. This attests to the cost-effectiveness of GDT in the management of a subset of patients at higher risk of morbidity and mortality after cardiac surgery.
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